VESPER-3 VESPER-3 was a 64-week placebo-controlled trial that assessed the efficacy and safety of monthly berobenatide in adults with obesity or overweight with hypertension and/or dyslipidemia
Nutrition, activity levels, and behavioral support play an important role in long-term success
Protein-Rich Meals: Enhancing GLP-1 Levels Pro Tip: Protein intake can increase GLP-1 levels, helping stabilize blood sugar and reduce hunger
Treatment is primarily supportive, including fluid resuscitation, pressors (dopamine, midodrine, etc.), pain management, wound cleaning, and infection prophylaxis/treatment
While still in trials, there are different types of delivery systems been studied for GLP-1 drug transdermal patches
The side effect profile for semaglutide is well-documented